Introduction - Your latest trial sponsor is using AI to accelerate protocol development and patient recruitment,[1] cutting ...

Researchers at Ben-Gurion University of the Negev (BGU)—with collaborators from the La Jolla Institute for Immunology (LJI)—have developed a new computational method for designing “super-peptides” ...

Scientists in China used computer analyses to identify two genes driving pulmonary arterial hypertension that may prove a ...

As generative intelligence optimizes facial features, the line between digital perfection and surgical reality fades into ...

MIT and Mecalux unveil GENESIS, an AI-powered simulator optimizing inventory and logistics, reducing costs, enhancing supply ...

Scientists use machine learning and SPERRFY to decode the genetic wiring map that guides neural connections across the entire ...

University of Portsmouth experts to host an engaging event exploring how Earth became habitable and how nature is inspiring ...

Doctors and patients are gaining an edge in the fight against Alzheimer’s disease by catching early warning signs with new screening methods.

New screening tools: Hospitals are piloting tablet-based cognitive exams and AI-driven brain scan analysis to spot Alzheimer’s signs invisible to human observers. Genetic risk insight: Patients can ...

Learn how AI medical discovery is bridging the gap between lab research and bedside treatments, resulting in faster and more ...

Ligand-based drug design combines AI and QSAR modeling to prioritize drug candidates, minimizing preclinical failures and ...

MicroAlgo QAS, by optimizing quantum circuit architectures, can significantly enhance the robustness of VQA in various noisy environments. By automatically searching for suitable circuit designs, QAS ...